Charles Schwab’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.4M | Buy |
|
|||||
|
2025
Q2 | $37.2M | Buy |
|
|||||
|
2025
Q1 | $39.3M | Buy |
|
|||||
|
2024
Q4 | $27.8M | Buy |
|
|||||
|
2024
Q3 | $29M | Buy |
|
|||||
|
2024
Q2 | $24.9M | Buy |
|
|||||
|
2024
Q1 | $24M | Buy |
|
|||||
|
2023
Q4 | $23.5M | Buy |
|
|||||
|
2023
Q3 | $20.3M | Buy |
|
|||||
|
2023
Q2 | $19.3M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Sell |
|
|||||
|
2022
Q4 | $19.3M | Buy |
|
|||||
|
2022
Q3 | $10.1M | Buy |
|
|||||
|
2022
Q2 | $8.21M | Buy |
|
|||||
|
2022
Q1 | $8.82M | Buy |
|
|||||
|
2021
Q4 | $7.83M | Buy |
|
|||||
|
2021
Q3 | $6.73M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $10.4M | Buy |
|
|||||
|
2020
Q4 | $14.4M | Buy |
|
|||||
|
2020
Q3 | $12.5M | Sell |
|
|||||
|
2020
Q2 | $14.9M | Buy |
|
|||||
|
2020
Q1 | $9.87M | Buy |
|
|||||
|
2019
Q4 | $16.6M | Buy |
|
|||||
|
2019
Q3 | $3.09M | Buy |
|
|||||
|
2019
Q2 | $1.46M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $70K | Hold |
|
|||||
|
2016
Q4 | $120K | Hold |
|
|||||
|
2016
Q3 | $140K | Hold |
|
|||||
|
2016
Q2 | $134K | Buy |
|